Format
Items per page
Sort by

Send to:

Choose Destination

Results: 7

Related Articles by Review for PubMed (Select 9555021)

1.

Effects of haloperidol metabolites on neurotransmitter uptake and release: possible role in neurotoxicity and tardive dyskinesia.

Wright AM, Bempong J, Kirby ML, Barlow RL, Bloomquist JR.

Brain Res. 1998 Mar 30;788(1-2):215-22.

PMID:
9555021
2.

Enzyme-catalyzed bioactivation of cyclic tertiary amines to form potential neurotoxins.

Castagnoli N Jr, Castagnoli KP, Van der Schyf CJ, Usuki E, Igarashi K, Steyn SJ, Riker RR.

Pol J Pharmacol. 1999 Jan-Feb;51(1):31-8. Review.

PMID:
10389142
3.

Potential metabolic bioactivation pathways involving cyclic tertiary amines and azaarenes.

Castagnoli N Jr, Rimoldi JM, Bloomquist J, Castagnoli KP.

Chem Res Toxicol. 1997 Sep;10(9):924-40. Review.

PMID:
9305573
4.

Haloperidol cytotoxicity and its relation to oxidative stress.

Raudenska M, Gumulec J, Babula P, Stracina T, Sztalmachova M, Polanska H, Adam V, Kizek R, Novakova M, Masarik M.

Mini Rev Med Chem. 2013 Dec;13(14):1993-8. Review.

PMID:
24160710
5.

Serotonin binding proteins: an in vitro model system for monoamine-related neurotoxicity.

Vauquelin G, Del Rio MJ, Pardo CV.

Ann N Y Acad Sci. 1994 Nov 17;738:408-18. Review. No abstract available.

PMID:
7832449
6.

Metabolism of haloperidol and its tetrahydropyridine dehydration product HPTP.

Usuki E, Van der Schyf CJ, Castagnoli N Jr.

Drug Metab Rev. 1998 Nov;30(4):809-26. Review. No abstract available.

PMID:
9844810
7.

Biogenic amine neurotransmitter transporters: just when you thought you knew them.

Blakely RD, DeFelice LJ, Galli A.

Physiology (Bethesda). 2005 Aug;20:225-31. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk